About Summus Global
Summus Global is a company based in New York (United States) founded in 2015 by Julian Flannery. Summus Global has raised $91.34 million across 6 funding rounds from investors including Danaher, Sator Grove Holdings and Glenstone. Summus Global offers products and services including Integrated Clinical Navigation, Oncology Program, Total Musculoskeletal, Women’s Health, and Heart Health. Summus Global operates in a competitive market with competitors including Amwell, Ro, MD Live, HealthTap and K Health, among others.
- Headquarter New York, United States
- Founders Julian Flannery
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Summus Global, Inc.
-
Annual Revenue
$861.77 K (USD)8as on Dec 31, 2022
-
Net Profit
-$121.33 K (USD)9as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$91.34 M (USD)
in 6 rounds
-
Latest Funding Round
$20 M (USD), Series C
Mar 26, 2026
-
Investors
Danaher
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Summus Global
Summus Global offers a comprehensive portfolio of products and services, including Integrated Clinical Navigation, Oncology Program, Total Musculoskeletal, Women’s Health, and Heart Health.
Platform for doctor-led guidance and specialist connections.
Personalized support for cancer prevention and treatment phases.
Program for surgical and non-surgical MSK needs.
Support across life stages from adolescence to menopause.
Preventive and treatment education for cardiac conditions.
People of Summus Global
Unlock access to complete
Unlock access to complete
Funding Insights of Summus Global
Summus Global has successfully raised a total of $91.34M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Summus Global
Summus Global has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Danaher, Sator Grove Holdings and Glenstone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage VC firm focused on disruptive industry founders.
|
Locked | Locked | Locked | |
|
Savoy Capital is engaged in financial or investment activities.
|
Locked | Locked | Locked | |
|
Venture capital is invested in consumer and enterprise software services.
|
Locked | Locked | Locked |
Investor details for Summus Global
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Summus Global
Investment portfolio details for Summus Global
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Summus Global
Detailed financials for Summus Global
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Summus Global Comparisons
Peer comparison for Summus Global
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Summus Global
Summus Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amwell, Ro, MD Live, HealthTap and K Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Telehealth solutions are provided for doctors and patients' consultations.
|
|
| Locked | Locked | Locked |
Digital health services for men's wellness are offered by Ro.
|
|
| Locked | Locked | Locked |
Cloud-based telemedicine consultations are offered 24/7 to patients nationwide.
|
|
| Locked | Locked | Locked |
Tech-enabled Q&A and video consultation platform for patients and doctors
|
|
| Locked | Locked | Locked |
Access to clinicians is facilitated by an AI-based healthcare platform.
|
|
| Locked | Locked | Locked |
Primary healthcare is delivered through telemedicine services.
|
Detailed competitors of Summus Global
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Summus Global
Complete news archive for Summus Global
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Summus Global
Summus Global was founded in 2015.
Summus Global is headquartered in New York, United States. It is registered at New York, New York, United States.
Julian Flannery is the current CEO of Summus Global. They have also founded this company.
Summus Global is a funded company, having raised a total of $91.34M across 6 funding rounds to date.
Annual revenue of Summus Global is $861.77K as on Dec 31, 2022.
SUMMUS GLOBAL offers an online platform that provides teleconsultation services for both patients and doctors and to top-tier physicians across a spectrum of specialty medicine. The online platform allows patients and doctors to search for a specialist physician and avail consultations online via video or call.
Summus Global offers Integrated Clinical Navigation, Oncology Program, Total Musculoskeletal, Women’s Health, and Heart Health.
Summus Global has 6 investors. Key investors include Danaher, Sator Grove Holdings, Glenstone, Outsiders Fund, and Savoy Capital.